Mean plasma concentrations increased from 132±177 ng/ml at baseline to 1590±513 ng/ml after levodopa administration.
The mean plasma concentrations of HAL were significantly (p<0.05) higher in patients with one mutated allele than in those with no mutated allele.
Mean study drug plasma concentrations measured on Days 7 and 8 before and after the tyramine test are presented in Table 2. Compared to Day 7, Day 8 pretest mean plasma concentrations (more than 24 h after the last dose) decreased by 61, 68, and 50% for duloxetine 80 mg/day, duloxetine 120 mg/day, and desipramine, respectively.
After GnRH treatment, mean plasma concentrations of all three hormones increased (P < 0.05) dramatically from 30 minutes and remained high until 120 minutes (LH), 75 minutes (INSL3), and 4 hours (testosterone) after treatment.
The mean plasma concentrations of each of the nine NAAs in normal adults measured after the subjects had fasted for 4 h are shown at Table 3.
The mean plasma concentrations of Hp were low at all postnatal ages with a nadir at P6 and a subsequent slow rise with increasing postnatal age (Fig. 4a).
Mean plasma concentrations of the DEHP metabolites were 45- to 280-times higher than normal upon PICU admission, decreased rapidly but remained 3- to 29-times elevated until PICU discharge (all P < 0.001).
The mean plasma concentrations of NT-proBNP in ARDS patients were higher than the normal values, with a trend for decrease during hospitalization: from 4706 (334-15173) pg/ml on admission to 1843 (118-10815) pg/ml and 1236 (332-11100) pg/ml on days 3 and 5, respectively (p > 0,05).
